Related Experiment Video
Updated: Feb 11, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Cardiac manifestations in sickle cell disease varies with patient genotype
Paul Guedeney1, François Lionnet2, Alexandre Ceccaldi1
1Sorbonne Universités, UPMC Univ Paris 06, Institut de Cardiologie (AP-HP), Centre Hospitalier Universitaire Pitié-Salpêtrière, Institute of Cardiometabolism and Nutrition (ICAN), INSERM UMRS 1166, ACTION Study Group, Paris, France.
Insights
Cardiac involvement differs between sickle cell anaemia (SCA) and Haemoglobin SC (HbSC) disease. SCA shows more left ventricular hypertrophy, while HbSC disease
Area of Science:
- Cardiology
- Hematology
- Genetics
Background:
- Cardiac involvement is well-defined in sickle cell anaemia (SCA).
- Cardiac manifestations in Haemoglobin SC (HbSC) disease remain largely uncharacterized.
- Understanding genotypic differences in cardiac complications is crucial for patient management.
Purpose of the Study:
- To compare cardiac features in patients with HbSC disease versus SCA patients.
- To identify determinants of cardiac involvement in both sickle cell genotypes.
- To establish genotype-specific echocardiographic findings and indications.
Main Methods:
- Echocardiography was used to assess left ventricular ejection fraction (LVEF), left ventricle mass index (LVMi), cardiac index, and peak tricuspid regurgitation velocity (TRV).
- LV filling pressures were evaluated using the E/e' ratio.
- Sixty HbSC patients were compared to 60 SCA patients and 60 age/gender-matched controls.
Main Results:
- Both HbSC and SCA patients showed higher LVMi than controls; LV hypertrophy was significantly more prevalent in SCA (45%) than HbSC (5%).
- SCA patients had elevated cardiac index and TRV, while HbSC patients' cardiac index and TRV were similar to controls.
- Both genotypes exhibited higher E/e' ratios than controls, indicating diastolic dysfunction. In SCA, cardiac involvement correlated with anaemia/haemolysis; in HbSC, it linked to hypertension/obesity.
Conclusions:
- Cardiac involvement and its underlying causes differ significantly between HbSC disease and SCA.
- SCA is associated with more pronounced left ventricular hypertrophy.
- Genotype-specific considerations are essential for echocardiographic assessment and interpretation in sickle cell disorders.
Abstract:
Cardiac involvement is well characterized in sickle cell anaemia (SCA) but cardiac features associated with Haemoglobin SC (HbSC) disease are mostly unknown. We compared 60 patients with HbSC disease (median age 31 years, 25 men) to 60 SCA patients and 60 controls matched for age and gender. Left ventricular ejection fraction (LVEF), left ventricle (LV) mass index (LVMi), cardiac index and peak tricuspid regurgitation velocity (TRV) were measured using echocardiography. LV filling pressures were assessed using the ratio of early diastolic transmitral velocity to tissue velocity (E/e' ratio). The LVMi was higher in both genotypes compared to controls. However, whereas LV hypertrophy was observed only in 3(5%) HbSC patients, this condition was diagnosed in 27(45%) SCA patients (P < 0·0001). While cardiac index and TRV were similar in HbSC compared to controls, SCA patients exhibited elevated cardiac output and TRV. LVEF was similar in the 3 groups. However, both genotypes had a higher E/e' ratio compared to controls. Cardiac involvement in SCA was related to anaemia and haemolysis, while LV diastolic dysfunction and TRV in HbSC disease patients were related to arterial hypertension and overweight comorbidities. In summary, cardiac involvement and its determinants are different in HbSC disease and SCA. Patient's genotype should be considered with regard to the echocardiographic indications and findings.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gradually Varying Flow

